drugset / Trial / NCT00633230

Effects of Sho-saiko-to, a Herbal Formula, in Reducing Viral Load in Hepatitis C

NCT00633230 ↗

Phase 1 Withdrawn University of Virginia
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to (1) determine the effects of the herbal formula Sho-saiko-to (SST) compared to placebo in treating hepatitis C virus (HCV) in persons who have not responded to the current conventional therapy (peginterferon alfa and ribavirin) or who have relapsed or in those for whom conventional therapy is contraindicated; (2) determine the influence that SST will have on participant reports of depression/sadness, fear and uncertainty related to the HCV disease progression, and renewal of hope in these individuals; and (3) collect preliminary data needed to examine feasibility, patient acceptance, and any potential limitations of the study.

Timeline

Start
—
Primary completion
—
Completion
—

Outcome

Outcome not reported

Stopped (Business): “No funding secured”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sho-saiko-to Traditional medicine (herbal / TCM) 2100 mg —